Correlation Between Sellas Life and Aligos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sellas Life and Aligos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Aligos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sellas Life Sciences and Aligos Therapeutics, you can compare the effects of market volatilities on Sellas Life and Aligos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Aligos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Aligos Therapeutics.

Diversification Opportunities for Sellas Life and Aligos Therapeutics

-0.48

Correlation Coefficient

Sellas Life  Aligos Therapeutics

Very good diversification

The 3 months correlation between Sellas and Aligos is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Aligos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aligos Therapeutics and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Aligos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aligos Therapeutics has no effect on the direction of Sellas Life i.e., Sellas Life and Aligos Therapeutics go up and down completely randomly.

Pair Corralation between Sellas Life and Aligos Therapeutics

Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 0.78 times more return on investment than Aligos Therapeutics. However, Sellas Life Sciences is 1.28 times less risky than Aligos Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Aligos Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  95.00  in Sellas Life Sciences on December 25, 2024 and sell it today you would earn a total of  30.50  from holding Sellas Life Sciences or generate 32.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sellas Life Sciences  vs.  Aligos Therapeutics

Sellas Life Sciences

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sellas Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Sellas Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

Aligos Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aligos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Sellas Life and Aligos Therapeutics

The main advantage of trading using opposite Sellas Life and Aligos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Aligos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos Therapeutics will offset losses from the drop in Aligos Therapeutics' long position.

The idea behind Sellas Life Sciences and Aligos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.